The tragedy of COVID-19 opened up a rare window of opportunity for innovators and leaders move the needle on both healthcare outcomes and healthcare costs. In this white paper, we outline how firms should take advantage of this unusual window to make huge gains with great digital health solutions, including connected medical devices, Software as a Medical Device (SaMD) and digital therapeutics (DTx).